{"title":"药品生产企业责任的法律基础","authors":"I. Barinova","doi":"10.18572/1812-3929-2023-2-62-66","DOIUrl":null,"url":null,"abstract":"The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.","PeriodicalId":81750,"journal":{"name":"Jurist (Washington, D.C.)","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Legal Fundamentals of Liability of Medicinal Products Manufacturers\",\"authors\":\"I. Barinova\",\"doi\":\"10.18572/1812-3929-2023-2-62-66\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.\",\"PeriodicalId\":81750,\"journal\":{\"name\":\"Jurist (Washington, D.C.)\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurist (Washington, D.C.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18572/1812-3929-2023-2-62-66\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurist (Washington, D.C.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18572/1812-3929-2023-2-62-66","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Legal Fundamentals of Liability of Medicinal Products Manufacturers
The author compares the concepts of ‘”circulation of medicines” and “pharmaceutical activity”. The main content of the text is an analysis of the responsibility of manufacturers for damage caused to the health of citizens by substandard, falsified medicines. The relevance lies in the fact that now, during the pandemic, special attention is being paid to new medicines. Due to the fact that they are a special type of product, they are subject to strict requirements for quality, safety and effectiveness, compliance with which also falls on manufacturers of medicines, which once again underlines the need for clearly defined responsibility of manufacturers of medicines. In conclusion, the author suggests possible changes in the legislation on the responsibility of the manufacturer of medicines.